From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Journal of the National Cancer Institute 2017 Jul 109 (7): .
Kuchenbaecker Karoline B, McGuffog Lesley, Barrowdale Daniel, Lee Andrew, Soucy Penny, Dennis Joe, Domchek Susan M, Robson Mark, Spurdle Amanda B, Ramus Susan J, Mavaddat Nasim, Terry Mary Beth, Neuhausen Susan L, Schmutzler Rita Katharina, Simard Jacques, Pharoah Paul D P, Offit Kenneth, Couch Fergus J, Chenevix-Trench Georgia, Easton Douglas F, Antoniou Antonis - Functionally null RAD51D missense mutation associates strongly with ovarian carcinoma.
Cancer research 2017 Jun .
Rivera Barbara, Di Iorio Massimo, Frankum Jessica, Nadaf Javad, Fahiminiya Somayyeh, Arcand Suzanna L, Burk David L, Grapton Damien, Tomiak Eva, Hastings Valerie, Hamel Nancy, Wagener Rabea, Aleynikova Olga, Giroux Sylvie, Hamdan Fadi F, Dionne-Laporte Alexandre, Zogopoulos George, Rousseau Francois, Berghuis Albert M, Provencher Diane, Rouleau Guy A, Michaud Jacques L, Mes-Masson Anne-Marie, Majewski Jacek, Bens Susanne, Siebert Reiner, Narod Steven A, Akbari Mohammad R, Lord Christopher J, Tonin Patricia N, Orthwein Alexandre, Foulkes William - High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.
BMC research notes 2017 Jun 10 (1): 188.
Laarabi Fatima-Zahra, Ratbi Ilham, Elalaoui Siham Chafai, Mezzouar Loubna, Doubaj Yassamine, Bouguenouch Laila, Ouldim Karim, Benjaafar Noureddine, Sefiani Abdelaz - Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer.
Breast care (Basel, Switzerland) 2017 May 12 (2): 114-116.
Sharma Bhai Pratibha, Sharma Deepak, Saxena Renu, Verma Ishwar - The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.
Journal of medical genetics 2017 May .
Moghadasi Setareh, Meeks Huong D, Vreeswijk Maaike Pg, Janssen Linda Am, Borg Åke, Ehrencrona Hans, Paulsson-Karlsson Ylva, Wappenschmidt Barbara, Engel Christoph, Gehrig Andrea, Arnold Norbert, Hansen Thomas Van Overeem, Thomassen Mads, Jensen Uffe Birk, Kruse Torben A, Ejlertsen Bent, Gerdes Anne-Marie, Pedersen Inge Søkilde, Caputo Sandrine M, Couch Fergus, Hallberg Emily J, van den Ouweland Ans Mw, Collée Margriet J, Teugels Erik, Adank Muriel A, van der Luijt Rob B, Mensenkamp Arjen R, Oosterwijk Jan C, Blok Marinus J, Janin Nicolas, Claes Kathleen Bm, Tucker Kathy, Viassolo Valeria, Toland Amanda Ewart, Eccles Diana E, Devilee Peter, Van Asperen Christie J, Spurdle Amanda B, Goldgar David E, García Encarna Góm
.png)
No hay comentarios:
Publicar un comentario